// App-Quantinova.ai

4084 : Lenalidomide and Dexamethasone in the Treatment of AL Amyloidosis: Final Results of A Phase II Trial

Researchers

Presenter

  • Vaishali Sanchorawala

Principal Investigators

  • Anthony C Shelton

  • Salli A Fennessey

  • Kathleen T Finn

  • Martha Skinner

  • Jerome B. Zeldis

  • David C Seldin

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Celgene Corporation

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Congestive heart failure

  • Venous thrombosis

  • AL Amyloidosis

  • Amyloid disease

  • Anemia

Biomarkers

  • Creatinine

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pomalidomide

  • CC-4047

  • Lenalidomide

  • Thalidomide

  • Melphalan

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT00091260

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved